We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.65%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$260B
AUM Growth
+$14.3B
(+5.8%)
Cap. Flow
-$9.91B
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
3,378
New
92
Increased
1,419
Reduced
1,604
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$292M |
| 2 |
Merck
MRK
|
+$239M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$232M |
| 4 |
Intuitive Surgical
ISRG
|
+$225M |
| 5 |
Walmart Inc
WMT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.01B |
| 2 |
Apple
AAPL
|
+$979M |
| 3 |
PPLI
People Inc
PPLI
|
+$793M |
| 4 |
Tesla
TSLA
|
+$671M |
| 5 |
Microsoft
MSFT
|
+$654M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.21% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 11.5% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
2001
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.15M | ﹤0.01% |
167,082
+1,416
| +0.9% | +$35.6K |
|
|
TAST
2002
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $4.15M | ﹤0.01% |
643,400
+460,229
| +251% | +$2.85M |
|
2003
Enanta Pharmaceuticals
ENTA
$400M
| $4.15M | ﹤0.01% |
90,587
-21,527
| -19% | -$1.04M |
|
|
SWTX
2004
DELISTED
SpringWorks Therapeutics
SWTX
| $4.14M | ﹤0.01% |
86,899
-176
| -0.2% | -$7.5K |
|
2005
LeMaitre Vascular
LMAT
$1.86B
| $4.12M | ﹤0.01% |
126,613
+407
| +0.3% | +$12.2K |
|
|
WDR
2006
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.1M | ﹤0.01% |
276,176
+38,844
| +16% | +$593K |
|
|
RAD
2007
DELISTED
Rite Aid Corporation
RAD
| $4.1M | ﹤0.01% |
431,976
+40,721
| +10% | +$581K |
|
2008
Stock Yards Bancorp
SYBT
$2.6B
| $4.1M | ﹤0.01% |
120,402
-24,316
| -17% | -$971K |
|
2009
Bank of Hawaii
BOH
$3.13B
| $4.09M | ﹤0.01% |
80,998
-3,456
| -4% | -$193K |
|
2010
Kelly Services Class A
KELYA
$528M
| $4.08M | ﹤0.01% |
239,661
-2,634
| -1% | -$44K |
|
2011
TFS Financial
TFSL
$4.93B
| $4.08M | ﹤0.01% |
277,766
-106,169
| -28% | -$1.55M |
|
2012
BioXcel Therapeutics
BTAI
$27.8M
| $4.08M | ﹤0.01% |
5,881
-3,807
| -39% | -$2.86M |
|
|
ADVM
2013
DELISTED
Adverum Biotechnologies
ADVM
| $4.08M | ﹤0.01% |
39,601
+4,033
| +11% | +$604K |
|
2014
Carpenter Technology
CRS
$28.4B
| $4.06M | ﹤0.01% |
223,440
+496
| +0.2% | +$10.7K |
|
2015
Buckle
BKE
$2.37B
| $4.05M | ﹤0.01% |
198,845
+64,268
| +48% | +$1.16M |
|
2016
Sterling Infrastructure
STRL
$16.7B
| $4.04M | ﹤0.01% |
285,633
-18,598
| -6% | -$234K |
|
2017
Vanguard Morningstar Small-Cap ETF
VB
$82.7B
| $4.04M | ﹤0.01% |
26,300
-79,700
| -75% | -$12.2M |
|
2018
GrowGeneration
GRWG
$90.7M
| $4.03M | ﹤0.01% |
252,260
+148,807
| +144% | +$1.77M |
|
2019
Simulations Plus
SLP
$371M
| $4.02M | ﹤0.01% |
53,310
+3,706
| +7% | +$238K |
|
|
CCXI
2020
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.01M | ﹤0.01% |
497,809
+63,428
| +15% | +$3.41M |
|
2021
Green Brick Partners
GRBK
$3.14B
| $4M | ﹤0.01% |
248,172
+19,060
| +8% | +$281K |
|
2022
Hope Bancorp
HOPE
$1.79B
| $3.99M | ﹤0.01% |
526,399
+36,955
| +8% | +$309K |
|
2023
Smith & Wesson
SWBI
$637M
| $3.99M | ﹤0.01% |
257,185
-115,250
| -31% | -$2.04M |
|
2024
Benchmark Electronics
BHE
$2.96B
| $3.99M | ﹤0.01% |
197,897
+9,957
| +5% | +$202K |
|
|
EBSB
2025
DELISTED
Meridian Bancorp, Inc.
EBSB
| $3.97M | ﹤0.01% |
383,902
-76,039
| -17% | -$862K |
|
Similar funds
VFT
Nuveen's Q3 2020 Portfolio in Review
As of Q3 2020, Nuveen held 3,378 positions worth $260B, up 5.8% from $246B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen withdrew a net $9.91B in Q3 2020, closing 90 positions and reducing 1,604 holdings. Its most notable exit was LogMein, Inc., an estimated $32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Nuveen opened a new position in Pactiv Evergreen Inc. Common stock worth $106M.
- Nuveen's largest Q3 2020 buy was Pactiv Evergreen Inc. Common stock: 8,319,656 shares worth $106M.
- Nuveen added most to JD.com in Q3 2020, an estimated $292M increase.
- Nuveen's biggest Q3 2020 reduction was Amazon, cutting an estimated $1.01B.
- Nuveen fully exited LogMein, Inc. in Q3 2020, selling an estimated $32M.
- Nuveen's ten largest holdings make up 23% of its $260B portfolio in Q3 2020.
- Nuveen opened 92 new positions and closed 90 in Q3 2020.
- Nuveen's portfolio value rose 5.8% quarter-over-quarter to $260B.
Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.